NeuroPace, Inc. NPCE 深 滬
等待開盤 05-15 09:30:00 美东时间
15.945
+0.135
+0.85%
華盛通- 最 高16.475
- 今 開16.04
- 成交量 7.70万股
- 最 低 15.5701
- 昨 收 15.81
- 總市值 5.41亿
- 52周最高 19.60
- 市盈率 靜 --
- 換手率 0.23%
- 52周最低 7.5625
- 委 比 98.81%
- 總股本 3395.04万
- 歷史最高 27.38
- 量 比 0.25
- 振 幅 5.72%
- 歷史最低 1.22
- 每 手 1
- 風險率 2.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Neuropace shares are trading lower. The company reported Q1 financial results.
Neuropace shares are trading lower. The company reported Q1 financial results.
05-13 21:19
NeuroPace Reports Q1 2026 Results: Full Earnings Call Transcript
NeuroPace (NASDAQ:NPCE) released first-quarter financial results and hosted an ...
05-13 05:38
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
Neuropace shares are trading higher after the company reported better-than-expected Q4 financial results.
Neuropace shares are trading higher after the company reported better-than-expe...
03-04 05:14
NeuroPace Sees FY2026 Sales $98.000M-$100.000M vs $98.943M Est
NeuroPace (NASDAQ:NPCE) sees FY2026 sales of $98.000 million-$100.000 million vs $98.943 million analyst estimate.
03-04 05:08
Earnings Summary: NeuroPace Q4
NeuroPace (NASDAQ:NPCE) reported its Q4 earnings results on Tuesday, March 3, 2...
03-04 05:08
Earnings Scheduled For March 3, 2026
Companies Reporting Before The Bell • On Holding (NYSE:ONON) is expected to rep...
03-03 19:11
Earnings Outlook For NeuroPace
NeuroPace (NASDAQ:NPCE) is preparing to release its quarterly earnings on Tuesd...
03-03 00:01
美股大行评级 | 瑞穗上调希捷科技、西部数据、CoreWeave目标价；Trade Desk、W.R. Berkley遭多家大行下调目标价
今日重点评级关注：瑞穗：维持Syndax制药"跑赢大市"评级，目标价从410美元升至600美元；HC Wainwright & Co.：维持60 Degrees Pharmaceuticals, Inc."买入"评级，目标价从6美元升至24美元
01-28 10:59
HC Wainwright & Co. Maintains Buy on NeuroPace, Raises Price Target to $19
HC Wainwright & Co. analyst Yi Chen maintains NeuroPace (NASDAQ:NPCE) with a Buy and raises the price target from $18 to $19.
01-27 19:19
